A Phase I Clinical Study of the Safety， Tolerability，Pharmacokinetics, and Initial Efficacy of HRS-6209 Monotherapy in Patients With Advanced Solid Tumors
Clinical trial NCT05781048 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05781048
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-23
- Primary completion
- 2026-12-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.